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ttp://dx.doi.org/10.1016/j.ajpath.2014.08.025Caspase-8 is an initiator and apical activator caspase that plays a central role in apoptosis. Caspase-8e
deﬁcient mice are embryonic lethal, which makes study of caspase-8 in primary immune cells difﬁcult. Recent
advances have rescued caspase-8edeﬁcient mice by crossing them to mice deﬁcient in receptor-interacting
serine-threonine kinase 3 (RIPK3). These genetic tools have made it possible to study the role of caspase-8
in vivo and in primary immune cells. Several recent studies have identiﬁed novel roles for caspase-8 in
modulating IL-1b and inﬂammation, showing that caspase-8 directly regulates IL-1b independent of
inﬂammasomes or indirectly through the regulation of inﬂammasomes, depending on the stimulus or stimuli
that initiate the signaling cascade. Here, we address recent ﬁndings on caspase-8 and its role in modulating
IL-1b and inﬂammation. (Am J Pathol 2015, 185: 17e25; http://dx.doi.org/10.1016/j.ajpath.2014.08.025)Supported by NIH grants R01 AR056296, R01 CA163507, and R01
AI101935 and the American Lebanese Syrian Associated Charities
(ALSAC) (T.-D.K.). P.G. is a postdoctoral fellow supported by a Paul
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Disclosures: None declared.Caspase-8 is an initiator and apical activator caspase that
plays a central role in apoptosis. It consists of two
N-terminal death effector domains (DEDs), which are fol-
lowed by a large (p18) and a small (p10) protease subunit at
the C-terminal end (Figure 1). First described in 1996,
caspase-8 is essential for death receptoreinduced activation
of the extrinsic cell-death pathway.1,2 On activation of death
receptors (CD95, TNFR1, or DR5), caspase-8 is recruited to
the receptors via the adaptor protein FAS-associated death
domain (FADD). Caspase-8 and FADD both contain DEDs,
which mediate DEDeDED homotypic interactions and
coordinate complex formation of death receptors. Caspase-8
homodimer formation in this complex results in activation
and autocleavage, which further stabilizes the active dimer.
Active caspase-8 then processes and cleaves downstream
executioner caspases, or the BCL2 family member BID, to
initiate apoptosis. Because apoptosis is central for devel-
opment and survival of the host, caspase-8 activation is
tightly regulated. cFLIP, a homolog of caspase-8, blocks
caspase-8 apoptotic function by forming heterodimeric
complexes3 (Figure 1). It has also been proposed that
caspase-8 is cleaved, and in some instances activated by
other caspases, such as caspase-34,5 and caspase-6,5,6 as
well as by the proteases granzyme B7 and cathepsin D.8
The importance of caspase-8 is highlighted by the fact that
knockout mice die at approximately embryonic day 10.5.9 Instigative Pathology.
.seminal studies, the Mocarski10 and Green11 research groups
showed that deletion of receptor-interacting serine-threonine
kinase 3 (RIPK3, involved in necroptotic cell death) rescues
caspase-8 deﬁcient mice. These studies established a non-
apoptotic role for caspase-8, namely, to rescue the lethality
induced by RIPK3-mediated pathways. The generation of
double-knockout Ripk3/Casp8/ mice has provided an
invaluable tool for investigating the role of caspase-8 in vivo
and in primary immune cells.
Here, we discuss inﬂammasome-mediated IL-1b pro-
duction and the novel roles of caspase-8 in modulating
inﬂammasomes, IL-1b, and inﬂammation.Inﬂammasomes and IL-1b
Inﬂammasomes
The term inﬂammasome was coined to describe a multimeric
protein complex containing a Nod-like receptor (NLR), an
adaptor protein (ASC), and a protease (caspase-1).12
Figure 1 Role for caspase-8 (CASP8) in inducing apoptosis and regulating signaling pathways. A: Procaspase-8 consists of two N-terminal death-effector
domain (DED) prodomains, which are followed by the catalytic subunits p18 and p10, respectively. On dimerization, caspase-8 is cleaved at the sites between
the DED and p18, and between p18 and p10. B: Death receptor (CD95, TNFR1, DR5) engagement with the respective ligand [CD95L, tumor necrosis factor alpha
(TNF-a), TNF-related apoptosis inducing ligand (TRAIL)] results in recruitment of FAS-associated death domain (FADD) and caspase-8 homodimers. Activation
of caspase-8 results in induction of apoptosis. cFLIP can bind to caspase-8 to form cFLIPecaspase-8 heterodimers. The formation of cFLIPecaspase-8
heterodimers inhibits apoptosis. C: Activation of Toll-like receptor 4 (TLR4) or TLR2 results in recruitment of TIR domain-containing adaptor-inducing
interferon-b (TRIF) and myeloid differentiation primary response protein MyD88 (MyD88) to the receptors. TRIF and MyD88 signaling results in downstream
nuclear factor-kB (NF-kB) signaling events that induce mRNA expression of proeIL-1b and NLRP3. Evidence suggests that FADD and caspase-8 are required for
optimal expression of proeIL-1b and NLRP3 mRNA, possibly through their role in NF-kB activation. LPS, lipopolysaccharide; PGN, peptidoglycan.
Gurung and KannegantiInﬂammasomes now also include AIM2, a member of the
HIN-200 family. Inﬂammasomes result in the activation of
caspase-1, which cleaves proeIL-1b and proeIL-18 into their
mature bioactive forms. NLRP1b,12 NLRP3,13e15 NLRC4,16
and AIM217,18 are the most well studied inﬂammasomes that
form this multimeric protein complex. Other inﬂammasomes
containing NLRP12,19 NLRP6,20 and pyrin21 have also been
identiﬁed, although further research is needed to establish
these NLRs as true inﬂammasomes. All of these upstream
receptors sense various stimuli that ultimately result in the
formation of the inﬂammasome complex. For example,
NLRP1b senses lethal toxin from Bacillus anthracis22;
NLRP3 senses various stimuli ranging from ATP, nigericin,
uric acid crystals, Escherichia coli, and Citrobacter roden-
tium13,15,23,24; NLRC4 senses ﬂagellin components of Sal-
monella typhimurium and Legionella pneumophila16,25; and
AIM2 senses free DNA in the cytoplasm.17,18Alternative Sources of IL-1b
Inﬂammasome-induced caspase-1 activation is a major source
of IL-1b. However, recent evidence suggests alternative sour-
ces of IL-1b release, independent of inﬂammasome-induced
caspase-1 activation. In particular, serine proteases such as
cathepsin C, cathepsin D, cathepsin G, neutrophil elastases,
and collagenases have been shown to be important in pro-
cessing IL-1b independent of caspase-1.26e30 In autoimmune
osteomyelitis, proline-serine-threonine phosphatase-interacting18protein 2 (PSTPIP2) deﬁciency induces IL-1b that is produced
independent of the inﬂammasomes.31,32 Moreover, caspase-8
has also been identiﬁed as an alternative protease that
can process IL-1b either in the inﬂammasomes or
independently.33e35 Recent reports suggest that caspase-8 is
critical for the NLRP3 inﬂammasome activation, which also
requires caspase-1 for IL-1b processing.23,36 In the following
sections, we discuss novel roles of caspase-8 as a direct pro-
tease for IL-1b, as well as its role as a direct regulator of the
NLRP3 inﬂammasome.Caspase-8eMediated Regulation of IL-1b
Nonapoptotic Functions of Caspase-8 in Regulating
IL-1b Expression
In addition to regulating cell death, active caspase-8 regu-
lates inﬂammation by modulating IL-1b mRNA expression.
It is proposed that caspase-8 regulates activation of nuclear
factor-kB (NF-kB) to modulate inﬂammation. This non-
apoptotic function, however, does not require cleavage.37
Studies using transgenic mice that express noncleavable
caspase-8 (Casp8D387A) showed that these mice are born
normal.37 Although Casp8D387A cells exhibited impaired
apoptosis in response to CD95 ligand (CD95L), CD95-
induced activation of NF-kB and ERK signaling pathways
was intact.37 Initial studies in HEK293T cells demonstrated
that overexpression of caspase-8 induces activation ofajp.amjpathol.org - The American Journal of Pathology
Caspase-8 and IL-1b RegulationNF-kB.38e40 The alternative function of caspase-8 is not
dependent on its protease subunits, but rather on the pro-
domain containing the DED domains.38 Furthermore,
siRNA-mediated knockdown of caspase-8 demonstrated
that caspase-8 regulates inﬂammation induced by viral
components that activate intracellular receptors such as
RIG-I and MDA-5.41,42 Other studies hint at possible roles
for caspase-8 in NLRC4-mediated NF-kB activation.43,44
Nonetheless, a direct role for caspase-8 in modulating
NF-kB activation in a physiological condition has yet to
be identiﬁed.
More recent studies using Ripk3/Casp8/ primary
macrophages have conﬁrmed a role for caspase-8 as tran-
scriptional regulator of the Il1b gene in response to lipo-
polysaccharide (LPS), Pam3CSK4 (a synthetic triacylated
lipopeptide that mimics bacterial lipopeptide), or infection
with Gram-negative bacteria such as S. typhimurium,
C. rodentium, and E. coli.36,45 Speciﬁcally, proeIL-1b up-
regulation on stimulation with S. typhimurium,
C. rodentium, or E. coli is dramatically reduced in Ripk3/
Casp8/ macrophages, compared with Ripk3/ macro-
phages. LPS and enteropathogens engage the TLR4eTRIF
[Toll-like receptor 4eToll-interleukin-1 receptor (TIR)
domain-containing adaptor protein inducing interferon-b
(alias TICAM-1)] signaling pathway,23 and it has been pro-
posed that caspase-8 can engage with TRIF.46,47 Our research
group recently showed that Il1b up-regulation induced by
TLR4eMyD88 (induced by Pam3CSK4) or NOD2 (induced
by MDP) is similarly hampered in Ripk3/Casp8/ mac-
rophages.36 Further studies are needed to elucidate how
caspase-8 regulates these signaling pathways and whether
caspase-8 also interacts with MyD88 and NOD2. Nonethe-
less, the various independent studies noted here suggest a
positive role for caspase-8 in regulating IL-1b expression by
potentially regulating the NF-kB signaling axis (Figure 1).
Caspase-8 Directly Cleaves IL-1b during Fungal
Infection
Caspase-8 can directly cleave proeIL-1b.33e35,48 Studies
with HEK293T cells overexpressing both caspase-8 and
proeIL-1b suggest that caspase-8 directly cleaves proeIL-
1b in response to stimulation by TLR3 or TLR4.49 Down-
stream TRIF-dependent signaling is important for activation
of caspase-8, which cleaves proeIL-1b at the same sites as
recombinant caspase-1 and produces similar mature IL-1b
fragments in vitro.49 Caspase-8 is the major protease that
cleaves proeIL-1b during infection with fungal pathogens
such as Candida albicans and Aspergillus fumigatus.48
However, these functions of caspase-8 are not limited to
fungal pathogens; indeed, caspase-8 is also important for IL-
1b processing during infection with Mycobacterium bovis
and M. leprae. Speciﬁcally, fungal components activate
dectin-1 receptor signaling to induce a noncanonical
CARD9eBCL10eMALT1eASC-caspase-8 complex.48 In
this complex, Syk signaling induces transcription ofThe American Journal of Pathology - ajp.amjpathol.orgproeIL-1b promoted by the CARD9eBCL10eMALT1
complex. Additional recruitment of ASC and caspase-8 to
the CARD9eBCL10eMALT1 complex activates caspase-8.
Activated caspase-8 then cleaves proeIL-1b independent of
both caspase-1 and the inﬂammasome complex (Figure 2).
These studies did not use primary Casp8/ macrophages, a
limitation that impedes our understanding of caspase-8
and its regulation of IL-1b in vivo. These functions
should be addressed in further studies taking advantage of
Ripk3/Casp8/ macrophages.
Death SignaleInduced IL-1b Processing Requires
Caspase-8
CD95-induced signaling induces caspase-8emediated cell
death.1,2 Caspase-8 is directly involved in cleavage and
activation of IL-1b during CD95L-induced IL-1b matura-
tion of TLR-primed macrophages and dendritic cells.34
These studies show that CD95 is up-regulated in both
dendritic cells and macrophages on TLR priming. Primed
myeloid cells can then activate caspase-8 on ligation of the
CD95 to its ligand CD95L (Figure 2). Although signiﬁcant
IL-1b production is observed in CD95L-stimulated wild-
type (WT) or Ripk3/ cells, IL-1b production in Ripk3/
Casp8/ cells is dramatically reduced. Furthermore,
CD95L-provoked IL-1b secretion is independent of ASC,
caspase-1, and caspase-11. Consistently, proapoptotic
chemotherapeutic drugs also induce IL-1b production by
LPS-primed dendritic cells.35 This IL-1b production is in-
dependent of the inﬂammasome components NLRP3,
NLRC4, and ASC and is also independent of caspase-1.
Similar to the CD95L ﬁndings, doxorubicin-induced IL-1b
processing35 is reduced in Ripk3/Casp8/ dendritic
cells, compared with Ripk3/ or WT dendritic cells, sug-
gesting a direct role for caspase-8 as a protease for proeIL-
1b processing. Taken together, these studies indicate that
caspase-8 acts as a major protease for processing proeIL-1b
and that caspase-8 can initiate inﬂammation in TLR-primed
macrophages or dendritic cells in response to death signals.
These results are paradoxical, considering that CD95 and
death receptor ligation induce apoptosis, whereas the release
of IL-1b is associated with pyroptosis (ie, inﬂammatory cell
death). Studies are needed to elucidate how TLR priming
before triggering of death receptors (CD95, TNFR1, or
DR5) or death signaling pathways (doxorubicin, staur-
osporine, oxaliplatin) induces inﬂammation by caspase-8.
Understanding the mechanistic and molecular un-
derpinnings of these pathways should be invaluable in
determining the multiple regulatory roles of caspase-8.Caspase-8 as a Protease during ER
StresseInduced Inﬂammation
Accumulation of unfolded proteins within the endoplasmic
reticulum (ER) stimulates the unfolded protein response19
Figure 2 Novel roles for caspase-8 in positive (A) and negative (B) regulation of IL-1b and the NLRP3 inﬂammasome. A: Fungal infection (left panel) induces
signaling through the dectin receptor and Syk activation. CARD9eBCL10eMALT1 complex formation induces NF-kB signaling and up-regulates proeIL-1b. Recruitment
of apoptosis-associated speck-like protein containing CARD (ASC) and caspase-8 to the CARD9eBCL10eMALT1 complex induces caspase-8 activation, which then
cleaves proeIL-1b to its mature form. Induction of apoptosis (middle panel) in the presence of LPS priming is accompanied by caspase-8edependent IL-1b pro-
cessing. CD95L signals through CD95 to recruit FADD and caspase-8 to the receptor and to induce apoptosis. In the presence of LPS, CD95L induces activation of caspase-
8 and caspase-8edependent IL-1b release. Chemotherapeutic drugs induce mitochondrial dependent intrinsic cell death. In the presence of LPS, doxorubicin and
oxaliplatin induce caspase-8 activation. Treatment of cells with tunicamycin and thapsigargin [known inducers of endoplasmic reticulum (ER) stress] in the presence of
LPS triggers caspase-8 activation. Active caspase-8 cleaves proeIL-1b to release mature IL-1b. In the NLRP3 inﬂammasome (right panel), caspase-8 is required for
both canonical and noncanonical NLRP3 inﬂammasome activation. Stimulation of TLR results in NF-kB activation and up-regulation of proeIL-1b and NLRP3mRNA that
is partially dependent on caspase-8. Stimulation of the canonical NLRP3 (LPSþATP, LPSþnigericin, Pam3CSK4þATP) or noncanonical NLRP3 (C. rodentium, E. coli)
inﬂammasome requires caspase-8 for assembly and activation of the NLRP3 inﬂammasome complex. Caspase-8 activation is required for activation of caspase-1 and
caspase-11. B: Caspase-8 is a negative regulator of LPS-induced activation of the NLRP3 inﬂammasome. In the absence of caspase-8, dendritic cells are hyper-
responsive to LPS stimulation and activate the NLRP3 inﬂammasome in a RIPK1-, RIPK3-, and MLKL-dependent manner. PAM, Pam3CSK4.
Gurung and Kannegantipathway known as ER stress. These programs are tightly
regulated for proper folding and generation of functional
proteins. Caspase-8 is central to the inﬂammation generated
during ER stress induced by the drugs tunicamycin or thap-
sigargin in LPS-primed macrophages33 (Figure 2). More
speciﬁcally, caspase-8 is involved in direct processing of
proeIL-1b into its mature form. The processing and matu-
ration of IL-1b are largely independent of both ASC and
caspase-1. ER stress contributes to various disease conditions
ranging from obesity, diabetes, Alzheimer disease, Parkinson
disease, and neurological damage more generally to several
types of infection. Thus, exploring the roles of caspase-8 is
important for the generation of novel therapeutics.50 Similar
to stimulation with CD95L or chemotherapeutic drugs, ER
stress also induces apoptosis.51
These studies suggest a novel role for caspase-8 in pro-
moting inﬂammation instead of apoptosis. The stimuli
(CD95L, chemotherapeutic drugs, ER stress) induce
apoptosis, whereas LPS triggers caspase-8einduced in-
ﬂammatory process that involves cleavage of proeIL-1b.
Furthermore, caspase-8 appears to be involved in several
different complexes, depending on the stimuli involved.
Although the dectin pathway comprises a large multiprotein
complex involving CARD9eBCL10eMALT1eASC and
caspase-8,48 ligation of CD95 or induction of apoptosis via
chemotherapeutic drugs or ER stress induces a unique
complex that does not require ASC.33e35 In this regard,
caspase-8 is promiscuous in its ability to form inﬂammatory
complexes to potentiate inﬂammation. Improved under-
standing of the conditions and milieu that promote20these complexes is needed, to shed light on the complex
caspase-8 biology.Caspase-8 and Regulation of the NLRP3
Inﬂammasome
NLRP3 Inﬂammasome
The NLRP3 inﬂammasome is one of the best-studied
inﬂammasomes, partly because of the promiscuity of
NLRP3 in its ability to be activated in response to a wide
array of stimuli.52 These stimuli range from environmental
factors (silica and asbestos crystals), endogenous danger
signals (uric acid and cholesterol crystals, ATP, reactive
oxygen species, and protein aggregates), and infections
(bacteria, viruses, and fungi). In the canonical NLRP3
inﬂammasome, activation of the inﬂammasome in response
to stimuli such as LPSþATP or LPSþnigericin does not
require caspase-11; by contrast, activation of the nonca-
nonical NLRP3 inﬂammasome during C. rodentium or
E. coli infection does require caspase-11 (Figure 2).53 The
ligand directly recognized by NLRP3 remains elusive.
Different stimuli result in common cellular perturbations,
such as potassium efﬂux and calcium mobilization, that
ultimately activate the NLRP3 inﬂammasome.54,55 Several
mutations in the NLRP3 gene have been found to cause
autoinﬂammatory disorders, including MuckleeWells syn-
drome and familial cold autoinﬂammatory syndrome, both
of which are associated with elevated IL-1b.13,56e58ajp.amjpathol.org - The American Journal of Pathology
Caspase-8 and IL-1b RegulationCaspase-8 as a Positive Regulator of the NLRP3
Inﬂammasome
Caspase-8 regulates the NLRP3 inﬂammasome.36,45,59,60
Genetic deletion of caspase-8 or its adaptor FADD on a
Ripk3/ background generates Ripk3/Casp8/ and
Ripk3/Fadd/ mice. Studies using macrophages and
dendritic cells from Ripk3/Casp8/ and Ripk3/
Fadd/mice demonstrate drastically reduced activation of
both the canonical (LPSþATP, LPSþnigericin) and non-
canonical (C. rodentium, E. coli) NLRP3 inﬂammasomes in
Ripk3/Casp8/ and Ripk3/Fadd/ cells, but not in
Ripk3/ or WT cells.36 Mechanistic studies revealed the
role of caspase-8 and FADD in both priming and activation
of the NLRP3 inﬂammasome complex.36 Speciﬁcally, both
caspase-8 and FADD are required for optimal induction of
proeIL-1b mRNA and protein after LPS stimulation or
C. rodentium and E. coli infection. Coimmunoprecipitation
and confocal studies conﬁrmed that caspase-8 is present in
the NLRP3 inﬂammasome complex, where it is involved in
cleavage and processing of procaspase-1. Furthermore,
caspase-8 is able to directly and speciﬁcally cleave caspase-1
in in vitro assays, which suggests a direct role for caspase-8 in
caspase-1 processing. Another study conﬁrmed the role for
caspase-8 in promoting S. typhimuriumeinduced IL-1b
production.45 S. typhimuriumeinduced proeIL-1b expres-
sion is blunted in Ripk3/Casp8/ but not Ripk3/ orWT
macrophages. Confocal studies conﬁrmed that caspase-8
colocalizes with ASC puncta after S. typhimurium infec-
tion; caspase-8 is thus activated and is involved in the pro-
cessing of proeIL-1b to its mature form. Furthermore,
Yersinia pestiseinduced caspase-1 activation and IL-1b
production is also dependent on caspase-8.61,62 In accord,
Listeria monocytogenes infection induces the production of
reactive oxygen species, which instigates association of
caspase-8 with ASC to promote IL-1b and IL-18 process-
ing.63 These ﬁndings variously conﬁrm a role for caspase-8
in promoting NLRP3 inﬂammasome activation via regula-
tion of both priming and post-transcriptional activation of the
inﬂammasome components.
Caspase-8 as a Negative Regulator of the NLRP3
Inﬂammasome and Inﬂammation
Kang et al64 reported a negative role for caspase-8 in LPS-
induced IL-1b production; Casp8/ dendritic cells (condi-
tional deletion of ﬂoxed caspase-8 driven by CD11c-Cre)
exhibited hyperactive production of IL-1b, compared with
WT controls. Mechanistic studies have shown that sponta-
neous activation of the NLRP3 inﬂammasome by LPS alone
is dependent on both RIPK1 and RIPK3.64 Indeed, genetic
deletion of RIPK3 in Casp8/ dendritic cells rescues LPS-
induced IL-1b production from Casp8/ dendritic cells,
and necrostatin-1 (a chemical inhibitor of RIPK1 kinase ac-
tivity) treatment inhibits LPS-induced IL-1b production from
Casp8/ dendritic cells.64 Furthermore, siRNA-mediatedThe American Journal of Pathology - ajp.amjpathol.orgdeletion of MLKL (a molecule that contributes to RIPK3-
dependent necrosis) also reduces LPS-induced IL-1b pro-
duction from Casp8/ dendritic cells. Therefore, caspase-8
negatively regulates RIPK1eRIPK3eMLKL-mediated
activation of the NLRP3 inﬂammasome.64 Findings from
another study support the negative role of caspase-8 in
regulation of dendritic cell activation.65 Several studies using
conditional caspase-8 deletion have demonstrated overt
inﬂammation in vivo, which supports a negative regulatory
role for caspase-8 in controlling inﬂammation.66e69 How-
ever, it remains to be determined whether these inﬂammatory
disorders are the result of speciﬁc activation of NLRP3
inﬂammasome in the absence of caspase-8.Explanations for Discrepancies among Studies
LPS-induced spontaneous activation of NLRP3 inﬂamma-
somes differs from LPSþATPeinduced activation of
NLRP3 inﬂammasomes, in that the levels of IL-1b pro-
duced by LPS stimulation alone are much less.64 Further-
more, LPS stimulation alone fails to induce appreciable
amounts of IL-1b in Ripk3/Casp8/ macrophages.36
Several differences in experimental systems could account
for the observed role of caspase-8 as either a positive or a
negative regulator of NLRP3 inﬂammasome, such as i) use
of Casp8/ dendritic cells versus the use of Ripk3/
Casp8/ macrophages; ii) LPS-induced IL-1b production
versus LPSþATP-induced IL-1b production; and iii) incom-
plete deletion of ﬂoxed caspase-8. Regardless of the direction
of regulation, these studies point toward caspase-8 playing a
very important role in regulating the NLRP3 inﬂammasome
and IL-1b. The present understanding of the roles of caspase-8
in regulating inﬂammatory processes is far from complete, and
further research is needed to sort out the differential roles of
caspase-8 in regulating the NLRP3 inﬂammasomes.Caspase-8 in Disease Pathogenesis
Caspase-8 is a critical modulator of cell death. Although
several caspase-8 mutations associated with tumors have
been attributed to loss of apoptotic functions,70e72 some
caspase-8 mutations have been observed to promote
enhanced NF-kB signaling in cancer cells.73 By contrast,
D302H mutations in caspase-8 have been associated with
reduced rates of cancer, although the precise molecular
mechanisms are not understood.74,75 Mice lacking
caspase-8 on a RIPK3-deﬁcient background (Ripk3/
Casp8/)11 or with caspase-8 conditionally deleted in
dendritic cells (Casp8ﬂ/:Itgax-Cre)64 have defects in cell
death and accumulation of lymphocytes, resulting in
splenomegaly and lymphadenopathy. Interestingly, pa-
tients with homozygous mutations in caspase-8 that result
in caspase-8 deﬁciency are developmentally normal,
suggesting redundancy in human caspase-8 function.76
Although such patients exhibit the expected defective21
Gurung and Kannegantilymphocyte apoptosis and homeostasis, the lymphocytes are
unable to undergo activation, resulting in severe immunode-
ﬁciency and increased rates of infection.76 Studies using
Ripk3/Casp8/ mice have shown a critical role for
caspase-8 in potentiating inﬂammation and protection in
response to C. rodentium36 and Y. pestis.61,62 Furthermore,
Ripk3/Casp8/ mice elicit a blunted response to LPS
shock and produce signiﬁcantly less IL-1b than littermate
controls.36
Studies using mice with conditional deletion (driven by
Cre) of ﬂoxed caspase-8 (Casp8ﬂ/ﬂ) in speciﬁc cells have
shown an opposite role. Mice with conditional deletion of
caspase-8 in dendritic cells (Casp8ﬂ/:Itgax-Cre mice) are
highly sensitive to LPS and succumb to LPS shock.64 Mice
expressing enzymatically inactive caspase-8 (Casp8C363S)
or mice with caspase-8 deleted in keratinocytes (Casp8ﬂ/:
Keratin5-Cre mice) develop inﬂammatory skin disease.67
Acute deletion of caspase-8 in the skin of adult mice
(tamoxifen-induced deletion of ﬂoxed caspase-8; Rosa26.-
CreERþ.Casp8ﬂ/ﬂ mice) also induces keratinocyte death and
inﬂammation.68 Similarly, acute deletion of caspase-8 in the
gut induces massive cell death, inﬂammation, sepsis, and
death in adult mice.68
These studies variously reveal the importance of caspase-8
in cancer, infection, and tissue homeostasis. In light of such
novel and controversial roles of caspase-8 in regulating
inﬂammasome and inﬂammation, further research is needed
to elucidate the molecular underpinnings of caspase-8 and
their roles in cancer and infectious diseases.Perspectives
Recent studies have indicated alternative roles for caspase-8
in signaling, metabolism, homeostasis, and controlling
necrotic cell death, and various roles have been identiﬁed for
caspase-8 in regulation of inﬂammasomes and IL-1b.
Caspase-8 forms novel complexes, depending on the type of
receptors and signaling pathways that are engaged. On liga-
tion of dectin receptors during fungal infections, caspase-8
assembles into a noncanonical multiprotein complex
comprising CARD9eBCL10eMALT1 and ASC.48 Once
activated within this complex, caspase-8 assumes an inﬂam-
matory role to further cleave and process proeIL-1b and to
initiate inﬂammation. In other settings, LPS-primed myeloid
cells activate caspase-8 on ligation with CD95,34 on treatment
with chemotherapeutic drugs such as doxorubicin or oxali-
platin,35 or on induction of ER stress by tunicamycin or
thapsigargin.33 Instead of inducing apoptosis, active caspase-8
cleaves proeIL-1b to initiate inﬂammation under these
conditions. It is unclear, however, how caspase-8 is acti-
vated under such stimulatory conditions or what kind of
complexes are formed. Intrinsic cell-death pathways
engaged by chemotherapeutic drugs or ER-stress inducers
are independent of caspase-8; however, caspase-8 is
engaged when these stimuli are present in combination with22LPS stimulation. The nature of caspase-8 activation in these
settings or of the complex within which caspase-8 is present
are not yet known. Understanding of these pathways can be
expected to contribute to improved therapeutics.
Several studies have shed light on the role of caspase-8
in directly regulating the NLRP3 inﬂammasome, in addi-
tion to its ability to directly regulate IL-1b up-regulation
and cleavage.36,45 During LPSþATP stimulation (canoni-
cal NLRP3 activation) or C. rodentium infection (nonca-
nonical NLRP3 activation), caspase-8 is present in the
NLRP3 inﬂammasome complex. In the inﬂammasome
complex, caspase-8 promotes caspase-1 cleavage and IL-
1b processing. Identiﬁcation of the ability of caspase-8 to
directly modulate the NLRP3 inﬂammasome reveals a
previously unknown role for caspase-8, and these studies
demonstrate how the apoptotic and inﬂammatory pathways
are tightly linked and regulated by caspase-8.
IL-1b is a pleiotropic cytokine, and deregulated IL-1b
production has been linked with several autoinﬂammatory
disorders.77e80 Several diseases (eg, diabetes, gout, Alz-
heimer disease) and autoinﬂammatory disorders (eg, oste-
omyelitis and cryopyrin-associated periodic syndrome)
result from uncontrolled IL-1b production. IL-1 receptor
antagonist protein (IL-1ra) has been used to treat these in-
ﬂammatory disorders, with great success.81 Recent studies,
however, have shown nonredundant roles for IL-1a and IL-
1b in contributing to disease outcomes,31,82 and because
both IL-1a and IL-1b signal through IL-1R, a more speciﬁc
targeting of the IL-1 pathways is required. Speciﬁc ability to
block caspase-8emediated IL-1b can be expected to ensure
the release of IL-1b (which might still be important for
combating infection) through other pathways that do not
require caspase-8. For instance, speciﬁc blockade caspase-8
will leave caspase-1 intact, which can process and release
IL-1b and IL-1a, critical for ﬁghting infections.
Conclusion
The role of caspase-8 apart from its function in apoptosis is
only beginning to unfold. To date, most studies have examined
the role of caspase-8 only in myeloid cells (speciﬁcally,
macrophages and dendritic cells). Because caspase-8 can play
such diverse roles and can engagemultiple proteins depending
on the stimuli present, it is conceivable that caspase-8 could
have completely different functions depending on the cell
types involved. Further studies and identiﬁcation of novel
pathways regulated by caspase-8 in regulating IL-1b produc-
tion in various cell types will undoubtedly be important in the
discovery of novel therapeutics to treat the related autoimmune
and autoinﬂammatory diseases.
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